Specialty Care Costs Higher for Patients With Bipolar Disorder Than Diabetes and Other Chronic DiseasesMay 22, 2009Mayo Clinic researchers have found that bipolar disorder (BPD) is a more costly chronic condition than diabetes, depression, asthma and coronary artery disease (CAD), based on a review of health care claim costs. Specialty care costs (the costs of seeing any specialist and all tests ordered) were especially higher for bipolar patients. Results of this review are being presented today at the Annual Meeting of the American Psychiatric Association in San Francisco. "Psychiatric care costs represented only a portion of the specialty care costs for these chronic conditions, explains Mark Williams, M.D., a Mayo Clinic psychiatrist and lead researcher. This suggests that many of the specialty costs for bipolar patients are not directly related to seeing a mental health provider." A data review of health care claims over a four-year period, showed patients with BPD had significantly higher total per member per month costs when compared with the other groups. Only patients with both CAD and diabetes had higher costs than patients with BPD. Total costs, specialty care visits, specialty care costs, outpatient psychiatric costs and outpatient psychiatric visits were compared. Mayo Clinic |
|||||||||||||||||||||
| Related Specialty Care Current Events and Specialty Care News Articles Telemedicine Expands Reach of Care for Parkinson's Patients A unique and innovative telemedicine project is providing distant nursing home patients with Parkinson's disease access to neurologists at the University of Rochester Medical Center (URMC). Telemedicine leads to better stroke treatment decisions Researchers at the University of California, San Diego Medical Center say that their first-of-its-kind study of a telemedicine program which transports stroke specialists via computer desktop or even laptop to the patient's bedside, using highly sophisticated video, audio and Internet technology, could have an immediate and profound impact on the treatment of stroke patients throughout the world. After ER visit, many patients in a fog, U-M study finds Every year, more than 115 million patients enter emergency rooms at hospitals around the nation. And more than three-quarters of them leave with an impression of what happened - or what should happen next - that doesn't match what their emergency care team would want. Prisoner HIV program leads to continuum of medical care after release By linking HIV positive prisoners to community-based medical care prior to release through an innovative program called Project Bridge, 95 percent of ex-offenders were retained in health care for a year after being released from incarceration, according to researchers from The Miriam Hospital. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care Research in the January issue of the Journal of the American College of Surgeons (JACS) shows that many patients with minimal injuries are being transferred from community hospitals to Level I and II trauma centers, despite the ability of the community hospitals to treat such injuries. Genetic test announced for suicidal ideation in patients using antidepressant drugs NeuroMark, a Boulder, Colorado company, announced today the immediate availability of a genetic test to identify people at risk of suicidal ideation-thoughts of committing suicide-when prescribed an antidepressant drug. Particular treatments effective for alcohol dependence Medical management combined with the drug naltrexone or with a specialized behavioral therapy can be effective treatments for alcohol dependence. Taking a Number of Medications Regularly Could Give You a Serious Headache If you frequently take over-the-counter pills or prescription medication to make your headaches go away, you might get relief-temporarily. But the frequent use of headache medications to make the pain of a headache disappear could trigger chronic daily headache (CDH), according to recent commentary appearing in Headache Currents. Numerous studies have highlighted similar conclusions about the overuse of medication, giving further weight to the expert opinions from Drs Fred Sheftell and Marcello Bigal of the New England Center for Headache. The Importance of Early Intervention in the Treatment of Rheumatoid Arthritis Study Indicates that Even a Few Months Delay in Implementing Drug Therapy Increases Long-Term Disease Severity and Joint Damage Findings Underscore the Urgency for Rapid Access of Patients to Specialist Care In a recent study, researchers found that the delay of treatment to patients with early Rheumatoid Arthritis (RA) significantly decreases the ability of traditional single-drug therapy to combat the disease`s debilitating symptoms. According to the study, which is published in the April 2002 issue of Arthritis & Rheumatism, a single-drug strategy is insufficient to achieve remission and prevent joint damage unless initiated at the onset of RA symptom More Specialty Care Current Events and Specialty Care News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||